Currently viewing the tag: "Treatment"
Even if it does not look like the Author is crowning NGAL as the winner as the “one-and-only-biomarker” for AKI:)
One of the reasons for this is the large variation on cut-off’s used… well – that we can change easily – in a jiffy 🙂 … it’s just a matter of Alere/abbott et al using […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard

